Intangible Assets, Net (Details) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Nov. 05, 2024 |
|
| Intangible Assets, Net [Line Items] | |||
| Intangible assets, gross | $ 418,867 | $ 418,867 | |
| Impairment expense | |||
| Amortization expense | 85,484 | $ 53,427 | |
| License [Member] | |||
| Intangible Assets, Net [Line Items] | |||
| Intangible assets, gross | $ 418,867 | ||
| Hupan Pharmaceutical [Member] | |||
| Intangible Assets, Net [Line Items] | |||
| Equity interest percentage | 100.00% | ||
| X | ||||||||||
- Definition Amount of amortization expense for finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, before accumulated amortization, of finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of impairment loss for finite- and indefinite-lived intangible assets, goodwill, and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|